Presentation TCT 2013 Renal Intervention: Indications and Patient Selection 2013 Presenter: Christopher White October 30, 2013 REGISTER for free or LOG IN to view this content Renovascular Presentation TCT 2013 Up Next Presentation TCT 2013 The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI Presenter: Deepak Bhatt October 30, 2013 More slides + Presentation TCT 2013 The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints) Presenter: Ted Feldman October 30, 2013 Presentation TCT 2013 Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time? Presenter: Deepak Bhatt October 30, 2013 We Recommend
Presentation TCT 2013 The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI Presenter: Deepak Bhatt October 30, 2013
Presentation TCT 2013 The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints) Presenter: Ted Feldman October 30, 2013
Presentation TCT 2013 Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time? Presenter: Deepak Bhatt October 30, 2013